GeneDx Holdings Corp. (WGS)
NASDAQ: WGS · Real-Time Price · USD
95.83
-5.75 (-5.66%)
At close: Feb 21, 2025, 4:00 PM
93.00
-2.83 (-2.95%)
After-hours: Feb 21, 2025, 5:55 PM EST
GeneDx Holdings Market Cap
GeneDx Holdings has a market cap or net worth of $2.63 billion as of February 21, 2025. Its market cap has increased by 2,583.53% in one year.
Market Cap
2.63B
Enterprise Value
2.61B
1-Year Change
2,583.53%
Ranking
Category
Stock Price
$95.83
Market Cap Chart
Since November 4, 2020, GeneDx Holdings's market cap has decreased from $17.90B to $2.63B, a decrease of -85.29%. That is a compound annual growth rate of -35.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 2.63B | 24.68% |
| Dec 31, 2024 | 2.11B | 2,866.28% |
| Dec 29, 2023 | 71.18M | -30.24% |
| Dec 30, 2022 | 102.04M | -90.52% |
| Dec 31, 2021 | 1.08B | -94.66% |
| Dec 31, 2020 | 20.16B | 12.65% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |